ArticleInternational immunopharmacology2021

Combination therapy of IFNβ1 with lopinavir-ritonavir, increases oxygenation, survival and discharging of sever COVID-19 infected inpatients.

Parvaneh Baghaei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.